One result of the European Union’s policy of leaving domestic drug policy to individual member states is that each one chooses its own path to medical cannabis, creating a variety of different regulatory schemes across the continent.
In Poland, the Parliament has begun debate on new legislation that would make cannabis available to tens of thousands of Poles with a wide range of health issues.
Click here to read the complete article
Lukas Hurt ~ Leafly.com via 420Intel.com ~
